Showing results (291-300 of 357) with videos related to
Sort By:
Pageof 36
Analytica Chimica Acta|August 29, 2007
Templated xerogels as platforms for biomolecule-less biomolecule sensorsZunyu Tao, Elizabeth C Tehan, Rachel M Bukowski, et al.Journal of Korean Medical Science|December 21, 2004
In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancerJeong-Heum Baek, Munna L Agarwal, Raymond R Tubbs, et al.The Cancer Journal From Scientific American|February 24, 2000
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escapeP Rayman, R G Uzzo, V Kolenko, et al.Cancer|July 12, 2008
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinomaBrian I Rini, Toni K Choueiri, Paul Elson, et al.Cancer Research|March 15, 1993
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptorsJ P Alexander, S Kudoh, K A Melsop, et al.Cancer Treatment Reports|July 1, 1983
Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group StudyF R Ahmann, F L Meyskens, S E Jones, et al.Cancer|November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumorsJ E Janik, M Sznol, W J Urba, et al.Cancer|June 20, 2007
Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapyToni K Choueiri, Jorge A Garcia, Paul Elson, et al.Cancer Research|February 1, 1991
Phase I trial of natural human interferon beta in metastatic malignancyR M Bukowski, J S Sergi, W J Sharfman, et al.The Journal of Clinical Investigation|September 24, 1999
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cellsR G Uzzo, P Rayman, V Kolenko, et al.Pageof 36